<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39271699</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Text mining method to unravel long COVID's clinical condition in hospitalized patients.</ArticleTitle><Pagination><StartPage>671</StartPage><MedlinePgn>671</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">671</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-024-07043-4</ELocationID><Abstract><AbstractText>Long COVID is characterized by persistent that extends symptoms beyond established timeframes. Its varied presentation across different populations and healthcare systems poses significant challenges in understanding its clinical manifestations and implications. In this study, we present a novel application of text mining technique to automatically extract unstructured data from a long COVID survey conducted at a prominent university hospital in S&#xe3;o Paulo, Brazil. Our phonetic text clustering (PTC) method enables the exploration of unstructured Electronic Healthcare Records (EHR) data to unify different written forms of similar terms into a single phonemic representation. We used n-gram text analysis to detect compound words and negated terms in Portuguese-BR, focusing on medical conditions and symptoms related to long COVID. By leveraging text mining, we aim to contribute to a deeper understanding of this chronic condition and its implications for healthcare systems globally. The model developed in this study has the potential for scalability and applicability in other healthcare settings, thereby supporting broader research efforts and informing clinical decision-making for long COVID patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Veras Florentino</LastName><ForeName>Pilar Tavares</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Medicina e Sa&#xfa;de P&#xfa;blica de Precis&#xe3;o (MeSP2), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Integra&#xe7;&#xe3;o de Dados e Conhecimentos para a Sa&#xfa;de (CIDACS), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ara&#xfa;jo</LastName><ForeName>Vin&#xed;cius de Oliveira</ForeName><Initials>VO</Initials><AffiliationInfo><Affiliation>Centro de Integra&#xe7;&#xe3;o de Dados e Conhecimentos para a Sa&#xfa;de (CIDACS), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zatti</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centro de Integra&#xe7;&#xe3;o de Dados e Conhecimentos para a Sa&#xfa;de (CIDACS), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luis</LastName><ForeName>Caio Vin&#xed;cius</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Departamento de Farmacologia, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavalcanti</LastName><ForeName>C&#xe9;lia Regina Santos</ForeName><Initials>CRS</Initials><AffiliationInfo><Affiliation>Departamento de Farmacologia, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Matheus Henrique Citibaldi</ForeName><Initials>MHC</Initials><AffiliationInfo><Affiliation>Departamento de Farmacologia, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xe3;o</LastName><ForeName>Anderson Henrique Fran&#xe7;a Figueredo</ForeName><Initials>AHFF</Initials><Identifier Source="ORCID">0000-0002-0721-0866</Identifier><AffiliationInfo><Affiliation>Departamento de Farmacologia, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertoldo Junior</LastName><ForeName>Juracy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro de Integra&#xe7;&#xe3;o de Dados e Conhecimentos para a Sa&#xfa;de (CIDACS), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>George G Caique</ForeName><Initials>GGC</Initials><AffiliationInfo><Affiliation>Centro de Integra&#xe7;&#xe3;o de Dados e Conhecimentos para a Sa&#xfa;de (CIDACS), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravera</LastName><ForeName>Ernesto</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Farmacologia, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cebukin</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departamento de Farmacologia, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>David</LastName><ForeName>Renata Bernardes</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Departamento de Farmacologia, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Melo</LastName><ForeName>Danilo Batista Vieira</ForeName><Initials>DBV</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Tales Mota</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Centro de Integra&#xe7;&#xe3;o de Dados e Conhecimentos para a Sa&#xfa;de (CIDACS), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diretoria de Tecnologia da Informa&#xe7;&#xe3;o, Universidade Federal de Ouro Preto, Ouro Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellei</LastName><ForeName>Nancy C J</ForeName><Initials>NCJ</Initials><AffiliationInfo><Affiliation>Disciplina de Mol&#xe9;stias Infecciosas, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boaventura</LastName><ForeName>Viviane</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Medicina e Sa&#xfa;de P&#xfa;blica de Precis&#xe3;o (MeSP2), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barral-Netto</LastName><ForeName>Manoel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5823-7903</Identifier><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Medicina e Sa&#xfa;de P&#xfa;blica de Precis&#xe3;o (MeSP2), Instituto Gon&#xe7;alo Moniz, Funda&#xe7;&#xe3;o Oswaldo Cruz, Salvador, Brazil. manoel.barral@fiocruz.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil. manoel.barral@fiocruz.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smaili</LastName><ForeName>Soraya S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0001-5844-1368</Identifier><AffiliationInfo><Affiliation>Departamento de Farmacologia, Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil. ssmaili@unifesp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="Y">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39271699</ArticleId><ArticleId IdType="pmc">PMC11399332</ArticleId><ArticleId IdType="doi">10.1038/s41419-024-07043-4</ArticleId><ArticleId IdType="pii">10.1038/s41419-024-07043-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Elpeltagy M, Sallam H. Automatic prediction of COVID&#x2013;19 from chest images using modified ResNet50. Multimed Tools Appl. 2021;80:26451&#x2013;63. 10.1007/s11042-021-10783-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11042-021-10783-6</ArticleId><ArticleId IdType="pmc">PMC8095476</ArticleId><ArticleId IdType="pubmed">33967592</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbar S, Mokbel M. The role of AI in digital contact tracing. In: Leveraging artificial intelligence in global epidemics. Gruenwald L, Jain S, Groppe S, editors. Academic Presss, Elsevier; 2021. pp. 203&#x2013;21.</Citation></Reference><Reference><Citation>Chowdhury MEH, Rahman T, Khandakar A, Mazhar R, Kadir MA, Mahbub ZB, et al. Can AI help in screening viral and COVID-19 pneumonia? IEEE Access. 2020;8:132665&#x2013;76.10.1109/ACCESS.2020.3010287</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2020.3010287</ArticleId></ArticleIdList></Reference><Reference><Citation>Cau R, Faa G, Nardi V, Balestrieri A, Puig J, Suri JS, et al. Long-COVID diagnosis: from diagnostic to advanced AI-driven models. Eur J Radiol. 2022;148:110164. 10.1016/j.ejrad.2022.110164</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2022.110164</ArticleId><ArticleId IdType="pmc">PMC8791239</ArticleId><ArticleId IdType="pubmed">35114535</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y-Y, Peng T-T, Yeh T-K, Huang W-Z, Chang S-E, Wu S-H, et al. Artificial intelligence approach fighting COVID-19 with repurposing drugs. Biomed J. 2020;43:355&#x2013;62. 10.1016/j.bj.2020.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7227517</ArticleId><ArticleId IdType="pubmed">32426387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Z, Zhan Z, Zhao Z, You Z, Liu Y, Yan Z, et al. Application of artificial intelligence in COVID-19 medical area: a systematic review. J Thorac Dis. 2021;13:7034&#x2013;53. 10.21037/jtd-21-747</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-21-747</ArticleId><ArticleId IdType="pmc">PMC8743418</ArticleId><ArticleId IdType="pubmed">35070385</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AM. A survey of current work in biomedical text mining. Brief Bioinforma. 2005;6:57&#x2013;71.10.1093/bib/6.1.57</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/6.1.57</ArticleId><ArticleId IdType="pubmed">15826357</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe9;v&#xe9;ol A, Dalianis H, Velupillai S, Savova G, Zweigenbaum P. Clinical natural language processing in languages other than English: opportunities and challenges. J Biomed Semant. 2018;9:12.10.1186/s13326-018-0179-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13326-018-0179-8</ArticleId><ArticleId IdType="pmc">PMC5877394</ArticleId><ArticleId IdType="pubmed">29602312</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha HAL, Solha EZM, Furtado V, Justino FL, Barreto LAL, Da Silva RG, et al. COVID-19 outbreaks surveillance through text mining applied to electronic health records. BMC Infect Dis. 2024;24:359. 10.1186/s12879-024-09250-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09250-y</ArticleId><ArticleId IdType="pmc">PMC10976796</ArticleId><ArticleId IdType="pubmed">38549109</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikhalishahi S, Miotto R, Dudley JT, Lavelli A, Rinaldi F, Osmani V. Natural language processing of clinical notes on chronic diseases: systematic review. JMIR Med Inf. 2019;7:e12239.10.2196/12239</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/12239</ArticleId><ArticleId IdType="pmc">PMC6528438</ArticleId><ArticleId IdType="pubmed">31066697</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W-Q, Teixeira PL, Mo H, Cronin RM, Warner JL, Denny JC. Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance. J Am Med Inform Assoc. 2016;23:e20&#x2013;7. 10.1093/jamia/ocv130</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv130</ArticleId><ArticleId IdType="pmc">PMC4954637</ArticleId><ArticleId IdType="pubmed">26338219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek M, Rayner C, Freyer A, Taylor S, J&#xe4;rte L, MacDermott N, et al. Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pr. 2021;71:e815&#x2013;25.10.3399/BJGP.2021.0265</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0265</ArticleId><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath LJ, Scott AM, Surinach A, Chambers R, Benigno M, Malhotra D. Use of the postacute sequelae of COVID-19 diagnosis code in routine clinical practice in the US. JAMA Netw Open. 2022;5:e2235089. 10.1001/jamanetworkopen.2022.35089</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.35089</ArticleId><ArticleId IdType="pmc">PMC9539719</ArticleId><ArticleId IdType="pubmed">36201207</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingery JR, Safford MM, Martin P, Lau JD, Rajan M, Wehmeyer GT, et al. Health status, persistent symptoms, and effort intolerance one year after acute COVID-19 infection. J Gen Intern Med. 2022;37:1218&#x2013;25. 10.1007/s11606-021-07379-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07379-z</ArticleId><ArticleId IdType="pmc">PMC8786200</ArticleId><ArticleId IdType="pubmed">35075531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28:2398&#x2013;405. 10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med. 2023;29:2347&#x2013;57. 10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Bai&#xe3;o F, Hamacher S, et al. Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9:407&#x2013;18. 10.1016/S2213-2600(20)30560-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30560-9</ArticleId><ArticleId IdType="pmc">PMC7834889</ArticleId><ArticleId IdType="pubmed">33460571</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira EA, Colosimo EA, Silva ACSE, Mak RH, Martelli DB, Silva LR, et al. Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil&#x2014;&#x101;uthors&#x2019; reply. Lancet Child Adolesc Health. 2021;5:e40&#x2013;2. 10.1016/S2352-4642(21)00277-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00277-7</ArticleId><ArticleId IdType="pmc">PMC8443233</ArticleId><ArticleId IdType="pubmed">34536362</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira-Silva T, Andrews JR, Boaventura VS, Ranzani OT, De Ara&#xfa;jo Oliveira V, Paix&#xe3;o ES, et al. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. Lancet Infect Dis. 2022;22:791&#x2013;801. 10.1016/S1473-3099(22)00140-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00140-2</ArticleId><ArticleId IdType="pmc">PMC8971277</ArticleId><ArticleId IdType="pubmed">35366959</ArticleId></ArticleIdList></Reference><Reference><Citation>Florentino PTV, Alves FJO, Cerqueira-Silva T, de Ara&#xfa;jo Oliveira V, J&#xfa;nior JBS, Penna GO, et al. Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil. Lancet Infect Dis. 2022;22:1669&#x2013;70. 10.1016/S1473-3099(22)00728-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00728-9</ArticleId><ArticleId IdType="pmc">PMC9640198</ArticleId><ArticleId IdType="pubmed">36356609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird S, Klein E, Loper E. Natural language processing with Python. 1st ed. Beijing; Cambridge [Mass]: O&#x2019;Reilly; 2009.</Citation></Reference><Reference><Citation>Cerqueira-Silva T, Katikireddi SV, De Araujo Oliveira V, Flores-Ortiz R, J&#xfa;nior JB, Paix&#xe3;o ES, et al. Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil. Nat Med. 2022;28:838&#x2013;43. 10.1038/s41591-022-01701-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01701-w</ArticleId><ArticleId IdType="pmc">PMC9018414</ArticleId><ArticleId IdType="pubmed">35140406</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimian M, Warner JL, Jain SK, Davis RB, Zerillo JA, Joyce RM. Significant and distinctive n-Grams in oncology notes: a text-mining method to analyze the effect of opennotes on clinical documentation. JCO Clin Cancer Inform. 2019;3:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6873977</ArticleId><ArticleId IdType="pubmed">31184919</ArticleId></ArticleIdList></Reference><Reference><Citation>Golz C, Richter D, Sprecher N, Gurtner C. Mental health-related communication in a virtual community: text mining analysis of a digital exchange platform during the Covid-19 pandemic. BMC Psychiatry. 2022;22:430. 10.1186/s12888-022-04080-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-022-04080-1</ArticleId><ArticleId IdType="pmc">PMC9233821</ArticleId><ArticleId IdType="pubmed">35752758</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;fer H, Teschler M, Mooren FC, Schmitz B. Altered tissue oxygenation in patients with post COVID-19 syndrome. Microvasc Res. 2023;148:104551. 10.1016/j.mvr.2023.104551</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2023.104551</ArticleId><ArticleId IdType="pmc">PMC10188192</ArticleId><ArticleId IdType="pubmed">37201676</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri G, Lococo S, Bertagna De Marchi L, Cecchetto A, Molena B, Arcaro G, et al. Persistent oxygen desaturation during exercise in patients with long COVID. Eur Respir J. 2022;60:3725.</Citation></Reference><Reference><Citation>Dom&#xe8;nech-Montoliu S, Puig-Barber&#xe0; J, Pac-Sa MR, Vidal-Utrillas P, Latorre-Poveda M, Del Rio-Gonz&#xe1;lez A, et al. Complications post-COVID-19 and risk factors among patients after six months of a SARS-CoV-2 infection: a population-based prospective cohort study. Epidemiologia. 2022;3:49&#x2013;67. 10.3390/epidemiologia3010006</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/epidemiologia3010006</ArticleId><ArticleId IdType="pmc">PMC9620887</ArticleId><ArticleId IdType="pubmed">36417267</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Katikireddi SV, Cerqueira-Silva T, Vasileiou E, Robertson C, Amele S, Pan J, et al. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil. Lancet. 2022;399:25&#x2013;35. 10.1016/S0140-6736(21)02754-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02754-9</ArticleId><ArticleId IdType="pmc">PMC8687670</ArticleId><ArticleId IdType="pubmed">34942103</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>